These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4174655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A, Dimitrov D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract] [Full Text] [Related]

  • 4. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F.
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo].
    Klöcking HP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Aug; 88(2):136-41. PubMed ID: 4174651
    [No Abstract] [Full Text] [Related]

  • 10. Modifications of bleeding time and intensity of prothrombin consumption and of fibrinolysis in rats after administration of platelet extracts alone and with antifibrinolytic agents.
    De Nicola P, Lüscher EF, Soardi F, Gibelli A, Cipolli PL.
    Farmaco Sci; 1967 Aug; 22(8):627-40. PubMed ID: 6077137
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):391-404. PubMed ID: 5314899
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [On the influence of natural and synthetic antifibrinolytic agents on the determination of the fibrin stabilizing factor (factor 13)].
    Vogel G, Sundermann A, König B.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Jun 30; 88(2):179-81. PubMed ID: 4174656
    [No Abstract] [Full Text] [Related]

  • 18. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W, Nicklisch S, Koster A, Spannagl M, Giersiefen H, van de Locht A.
    Anesthesiology; 2009 Jan 30; 110(1):123-30. PubMed ID: 19104179
    [Abstract] [Full Text] [Related]

  • 19. [On the effect of various antifibrinolytic agents on blood coagulation].
    Gerl D, Bonow A.
    Med Klin; 1969 Feb 28; 64(9):374-8. PubMed ID: 5783025
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of chelate-forming potassium-magnesium-d,l-asparginates on thrombocytic function and blood coagulation].
    Ruhstrat K, Marcsek M, Bierstedt P.
    Arzneimittelforschung; 1969 Sep 28; 19(9):1566-71. PubMed ID: 5394534
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.